Takara Bio Usa, Inc.
San Jose, CA Doing business as Takara Bio USA Takara Bio Usa, Inc.
- UEI
- SCQNFFL3RJD9
- CAGE
- 0PAF1
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 2560 Orchard Pkwy, San Jose, CA 95131, USA
- Website
- takarabio.com
- Employees
- 251-1K
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Niaaa: supply: takara BIO seeker reagents: n/a | Office of Logisitics and Acquisition Operations | $16,046 | |
| Preventative maintenance services for a becton dickinson 3 laser facslyric flow cytometer with universal loader. The… | Office of Logisitics and Acquisition Operations | $26,816 | |
| 26-005759 retronectin GMP grade - 2.5 ML | Office of Logisitics and Acquisition Operations | $24,601 | |
| Nichd: supply: trekker, in vitro diagnostic substances, reagents, test kits and sets: severable | National Institute of Child Health and Human Development | $11,771 | |
| Takara BIO USA, INC.:1109645 [25-002389] ICELL8 service contract, 1 year (420000044)POP: 06/16/2025 to 06/15/2026 | National Insititue of Arthritis and Musculoskeletal and Skin Diseases | $24,900 |
About Takara Bio Usa, Inc.
Takara Bio Usa, Inc., doing business as Takara Bio USA, is a San Jose, California-based for-profit manufacturer of biomedical products and life sciences research tools that sells reagents, kits, instruments, and maintenance services to federal research agencies exclusively as a prime contractor (100% of awards). The company competes full-and-open across its prime footprint with no set-aside designations on the majority of work; one Total Small Business set-aside purchase order appears in recent awards. Takara Bio USA has held federal contracts since at least 2001 and operates across primary NAICS codes centered on biological product manufacturing (179 awards), analytical laboratory instrument manufacturing (31 awards), and in-vitro diagnostic substance manufacturing (17 awards).
The customer base concentrates heavily within the National Institutes of Health and related HHS research components. The National Cancer Institute leads by both award count and dollar value (44 awards, $1.1 million combined potential value), followed by the NIH Clinical Center (16 awards, $804 thousand), the National Institute of Allergy and Infectious Diseases (18 awards, $336 thousand), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (7 awards, $311 thousand), and the Environmental Protection Agency's Office of Research and Development (14 awards, $225 thousand). These five customers account for 60% of combined potential value across the entire award portfolio. Representative recent work includes a $26,816 maintenance contract for a Becton Dickinson 3-laser FACSLyric flow cytometer at the NIH Clinical Center (June 2026), a $24,601 purchase order from the NIH Clinical Center for RetroNectin GMP grade reagent to support cellular therapy manufacturing (May 2026), and a $35,232 delivery of SmartScribe Reverse Transcriptase and SeqAmp DNA kits to the National Institute of Allergy and Infectious Diseases (June 2024). Historical work includes COVID-19 research support through reverse transcriptase and reagent procurements from NIAID beginning in 2021.
Activity has declined moderately over the past five years: six awards in 2022, five each in 2023 and 2024, three in 2025, and three thus far in 2026. The combined potential value across all 570 prime awards totals $4.7 million with $4.6 million obligated (99% of ceiling). Only two awards with completion dates in the next twenty-four months carry combined potential value of $43 thousand, representing minimal near-term recompete exposure. Takara Bio USA holds task order positions under at least three parent vehicles: an NIH indefinite delivery contract (HHSN261201400019I) with five task orders worth $127 thousand, and two additional IDCs and blanket purchase agreements with lower activity. The company operates no subcontract relationships in federal work; 100% of its federal footprint consists of prime contractor roles supplying reagents, kits, and services directly to government research facilities.
Quick answers
What is Takara Bio Usa, Inc.'s UEI?
Takara Bio Usa, Inc.'s Unique Entity ID (UEI) in SAM.gov is SCQNFFL3RJD9.
What is Takara Bio Usa, Inc.'s CAGE code?
Takara Bio Usa, Inc.'s CAGE code is 0PAF1.
What is Takara Bio Usa, Inc.'s primary NAICS code?
Takara Bio Usa, Inc.'s primary NAICS code is 325414 (Biological Product (except Diagnostic) Manufacturing).
Where is Takara Bio Usa, Inc. located?
Takara Bio Usa, Inc.'s physical address in SAM.gov is 2560 Orchard Pkwy, San Jose, CA 95131, USA.
Is Takara Bio Usa, Inc. registered in SAM.gov?
Yes. Takara Bio Usa, Inc.'s SAM.gov registration is active through August 27, 2027.
What is Takara Bio Usa, Inc.'s most recent federal award?
Takara Bio Usa, Inc.'s most recent federal contract award is Niaaa: supply: takara BIO seeker reagents: n/a (75N98026P00754), from Office of Logisitics and Acquisition Operations, on June 15, 2026.
On GovTribe
See Takara Bio Usa, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors